Aastrom Biosciences, Inc. (ASTM) to Host Second Quarter 2012 Investor Call on August 7, 2012
8/3/2012 10:24:39 AM
ANN ARBOR, Mich., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, will hold a second quarter investor call on Tuesday, August 7, 2012 at 4:30 pm (EDT). Dr. Grayson Wheatley, III, MD, FACS, of the Arizona Heart Institute, will join Aastrom's senior management on the call to discuss his experience treating patients with critical limb ischemia and his participation in Aastrom's clinical development programs for CLI.
comments powered by